www.fdanews.com/articles/183281-fda-approves-tandems-insulin-pump
![FDA_Logo_Blue_2016.gif](https://www.fdanews.com/ext/resources/test/Drug-Images4/FDA_Logo_Blue_2016.gif?t=1578316591&width=430)
FDA Approves Tandem’s Insulin Pump
August 29, 2017
Tandem Diabetes Care received FDA approval and announced the commercial launch of the t:slim X2 Insulin Pump with Dexcom G5 Mobile continuous glucose monitoring integration.
The device is the first sensor-augmented insulin pump approved to let users make treatment decisions without pricking their finger.
The software featured on this pump will also be available to current t:slim X2 Pump users at no cost using the remote software update. This is Tandem’s fifth new insulin pump launch in five years and the second featuring Dexcom technology.